Journal article icon

Journal article

Selective P450BM3 hydroxylation of the spiro[3.3]heptane core as a route to potential drug fragment molecules

Abstract:
Engineered P450BM3 enzyme variants, developed from an initial screening panel of 42 enzymes, convert N-benzyl spiro[3.3]heptane-2-carboxamide into three distally monohydroxylated regioisomers with essentially complete enantioselectivity. Two a-hydroxyamide derivatives are also produced. Elaboration of the metabolites by tethered C–H amination leadsto spiro[3.3]heptane motifs substituted with three different functional groups ready for further derivatization.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1021/acs.orglett.5c01265

Authors

More by this author
Institution:
University of Oxford
Division:
MPLS
Department:
Chemistry
Sub department:
Chemistry Research Laboratory
Role:
Author
ORCID:
0000-0003-4875-1092
More by this author
Institution:
University of Oxford
Division:
MPLS
Department:
Chemistry
Sub department:
Organic Chemistry
Oxford college:
Brasenose College
Role:
Author
ORCID:
0000-0002-6809-8265


Publisher:
American Chemical Society
Journal:
Organic Letters More from this journal
Volume:
27
Issue:
36
Pages:
9849–9853
Publication date:
2025-08-27
Acceptance date:
2025-08-22
DOI:
EISSN:
1523-7052
ISSN:
1523-7060


Language:
English
Pubs id:
2283652
Local pid:
pubs:2283652
Deposit date:
2025-08-22
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP